One-pot preparation of a novel CO-releasing material based on a CO-releasing molecule@metal-organic framework system.

A novel CO releasing material has been prepared via a one-pot synthesis-encapsulation strategy using the hierarchical metal organic framework [Zn2(dhtp)] (dhtp = 2,5-dihydroxyterephthalate) as a host of the photoactivable molybdenum tricarbonyl complex [Mo(CNCMe2CO2H)3(CO)3].

New insights into the chemistry of fac-[Ru(CO)3]²âº fragments in biologically relevant conditions: the CO releasing activity of [Ru(CO)3Cl2(1,3-thiazole)], and the X-ray crystal structure of its adduct with lysozyme.

Complexes of the general formula fac-[Ru(CO)(3)L(3)](2+), namely CORM-2 and CORM-3, have been successfully used as experimental CO releasing molecules (CO-RMs) but their mechanism of action and delivery of CO remain unclear. The well characterized complex [Ru(CO)(3)Cl(2)(1,3-thiazole)] (1) is now studied as a potential model CO-RM of the same family of complexes using LC-MS, FTIR, and UV-vis spectroscopy, together with X-ray crystallography. The chemistry of [Ru(CO)(3)Cl(2)(1,3-thiazole)] is very similar to that of CORM-3: it only releases residual amounts of CO to the headspace of a solution in PBS7.4 and produces marginal increase of COHb after long incubation in whole blood. 1 also reacts with lysozyme to form Ru adducts. The crystallographic model of the lysozyme-Ru adducts shows only mono-carbonyl Ru species. [Ru(H(2)O)(4)(CO)] is found covalently bound to a histidine (His15) and to two aspartates (Asp18 and Asp119) at the protein surface. The CO release silence of both 1 and CORM-3 and their rapid formation of protein-Ru(CO)(x)(H(2)O)(y) (x=1,2) adducts, support our hypothesis that fac-[Ru(CO)(3)L(3)] CO-RMs deliver CO in vivo through the decay of their adducts with plasma proteins.

Therapeutic potential of carbon monoxide in multiple sclerosis.

Carbon monoxide (CO) is produced during the catabolism of free haem, catalyzed by haem oxygenase (HO) enzymes, and its physiological roles include vasodilation, neurotransmission, inhibition of platelet aggregation and anti-proliferative effects on smooth muscle. In vivo preclinical studies have shown that exogenously administered quantities of CO may represent an effective treatment for conditions characterized by a dysregulated immune response. The carbon monoxide-releasing molecules (CORMs) represent a group of compounds capable of carrying and liberating controlled quantities of CO in the cellular systems. This review covers the physiological and anti-inflammatory properties of the HO/CO pathway in the central nervous system. It also discusses the effects of CORMs in preclinical models of inflammation. The accumulating data discussed herein support the possibility that CORMs may represent a novel class of drugs with disease-modifying properties in multiple sclerosis.

Towards improved therapeutic CORMs: understanding the reactivity of CORM-3 with proteins.

The biological role of carbon monoxide (CO) has completely changed in the last decade. Beyond its widely feared toxicity, CO has revealed a very important biological activity as a signaling molecule with marked protective actions namely against inflammation, apoptosis and endothelial oxidative damage. Its direct use as a therapeutic gas showed significant and consistent positive results but also intrinsic severe limitations. The possibility of replacing the gas by pro-drugs acting as CO-Releasing Molecules (CO-RMs) has clearly been demonstrated with several experimental compounds. Transition metal carbonyls complexes have proven to be the most versatile experimental CO-RMs so far. Presently, the challenge is to equip them with drug-like properties to turn them into useful pharmaceuticals. This requires studying their interactions with biological molecules namely those that control their pharmacokinetic and ADME profiles like the plasma proteins. In this account we analyze these questions and review the existing interactions between Metal Carbonyls and proteins. The recently explored case of CORM-3 is revisited to exemplify the methodologies involved and the importance of the results for the understanding of the mode of action of such pro-drugs.

Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1.

We have evaluated the effects of the carbon monoxide-releasing molecule CORM-A1 [Na(2) (BH(3) CO(2) ); ALF421] on the development of relapsing-remitting experimental allergic encephalomyelitis (EAE) in SJL mice, an established model of multiple sclerosis (MS). The data show that the prolonged prophylactic administration of CORM-A1 improves the clinical and histopathological signs of EAE, as shown by a reduced cumulative score, shorter duration and a lower cumulative incidence of the disease as well as milder inflammatory infiltrations of the spinal cords. This study suggests that the use of CORM-A1 might represent a novel therapeutic strategy for the treatment of multiple sclerosis.

The effect of the sixth sulfur ligand in the catalytic mechanism of periplasmic nitrate reductase.

The catalytic mechanism of nitrate reduction by periplasmic nitrate reductases has been investigated using theoretical and computational means. We have found that the nitrate molecule binds to the active site with the Mo ion in the +6 oxidation state. Electron transfer to the active site occurs only in the proton-electron transfer stage, where the Mo(V) species plays an important role in catalysis. The presence of the sulfur atom in the molybdenum coordination sphere creates a pseudo-dithiolene ligand that protects it from any direct attack from the solvent. Upon the nitrate binding there is a conformational rearrangement of this ring that allows the direct contact of the nitrate with Mo(VI) ion. This rearrangement is stabilized by the conserved methionines Met141 and Met308. The reduction of nitrate into nitrite occurs in the second step of the mechanism where the two dimethyl-dithiolene ligands have a key role in spreading the excess of negative charge near the Mo atom to make it available for the chemical reaction. The reaction involves the oxidation of the sulfur atoms and not of the molybdenum as previously suggested. The mechanism involves a molybdenum and sulfur-based redox chemistry instead of the currently accepted redox chemistry based only on the Mo ion. The second part of the mechanism involves two protonation steps that are promoted by the presence of Mo(V) species. Mo(VI) intermediates might also be present in this stage depending on the availability of protons and electrons. Once the water molecule is generated only the Mo(VI) species allow water molecule dissociation, and, the concomitant enzymatic turnover.

Stepwise hapticity changes in sequential one-electron redox reactions of indenyl-molybdenum complexes: combined electrochemical, ESR, X-ray, and theoretical studies.

Reduction of the dication [(eta5-Ind)(Cp)Mo[P(OMe)3]2]2+ (1(2+)) and oxidation of the neutral complex (eta3-Ind)(Cp)Mo[P(OMe)3]2 (1) proceed through a one-electron intermediate, 1+. The structures of 1(2+) and 1 have been determined by X-ray diffraction studies, which show the slip-fold distortion angle, Omega, of the indenyl ring increasing from 4.1 degrees in 1(2+) to 21.7 degrees in 1. Cyclic voltammetry and bulk electrolysis were employed to define the thermodynamics and heterogeneous charge-transfer kinetics of reactions 1(2+) + e(-) <==> 1+ and 1+ + e(-) <==> 1: DeltaE1/2 = 113 mV in CH3CN and 219 mV in CH2Cl2/0.1 M [NBu4][PF6]; k(s) = 0.4 cm x s(-1) for 1(2+)/1+ couple, 1.0 cm x s(-1) for 1+/1 couple in CH3CN. ESR spectra of 1+ displayed a surprisingly large hyperfine splitting (7.4 x 10(-4) x cm(-1)) from a single 1H nucleus, and spectra of the partially deuterated indenyl analogue confirmed assignment of a(H) to the H2 proton of the indenyl ring. The related eta5 18-electron complexes [(eta5-Ind)(Cp)Mo(dppe)]2+ (2(2+)) (dppe = diphenylphosphinoethane) and (eta5-Ind)(Cp)Mo(CN)2 (3) may also be reduced in two successive one-electron steps; ESR spectra of the radicals 2+ and 3- showed a similarly large a(H2) (8.7 x 10(-4) and 6.4 x 10(-4) x cm(-1), respectively). Molecular orbital calculations (density functional theory, DFT, and extended Hückel, EH) predict metal-indenyl bonding in 1+ that is approximately midway between that of the eta5 and eta3 hapticities (e.g., Omega = 11.4 degrees ). DFT results show that the large value of a(H2) arises from polarization of the indenyl-H2 by both inner-sphere orbitals and the singly occupied molecular orbital (SOMO) of 1+. The measured ks values are consistent with only minor inner-sphere reorganizational energies being necessary for the electron-transfer reactions, showing that a full eta5/eta3 hapticity change may require only small inner-sphere reorganization energies when concomitant with a pair of stepwise one-electron-transfer processes. The indenyl ligand in 1+ is best described as donating approximately four pi-electrons to Mo by combining a traditional eta3 linkage with two "half-strength" Mo-C bonds.